Reata Pharmaceuticals Announces Presentations at Upcoming Medical Conferences

NEXT STORY
Roche’s Evrysdi approved by European Commission as first and only at home treatment for spinal muscular atrophy
PREV STORY
Cellectis Establishes an At-The-Market (ATM) Program on Nasdaq
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for Epidiolex® (cannabidiol) in the treatment of Lennox-Gastaut syndrome and Dravet syndrome

LONDON and CARLSBAD, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) ...

author_avatar
NASDAQ Market News

Oxford Immunotec Applauds Updated Guidelines from the American Academy of Pediatrics Supporting Expanded Use of the T-SPOT®.TB Test

OXFORD, United Kingdom and MARLBOROUGH, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec ...

author_avatar
NASDAQ Market News

AB Science will hold an Investor & Analyst conference on masitinib in Amyotrophic Lateral Sclerosis (ALS) in New York, USA, on June 13, 2016

Following recommendation by the European Medicines Agency (EMA) to file masitinib for conditional marketing ...

author_avatar
NASDAQ Market News